Education and training
- MD (Medicine) | DM (Medical Oncology, TMH-Mumbai)
Medical Oncology
Dr. Mridul Malhotra
Cancer Care
Current designationConsultant - Medical Oncology
Published hospital associationManipal Hospital, Dwarka, New Delhi
ExperienceConfirm with hospital
Introduction
Introducing Dr. Mridul Malhotra
A concise, source-led overview for international patients considering specialist review in India.
Dr. Mridul Malhotra is Consultant - Medical Oncology at Manipal Hospital, Dwarka, New Delhi. The hospital-published profile identifies the clinical focus as Cancer Care. Published areas include Cancer Care, Precision Oncology: Tailoring treatment plans for cancer patients based on genomic testing and molecular profiling., Solid Tumor Management: Specializing in the diagnosis and treatment of solid tumors, including but not limited to:.
Dr. Mridul Malhotra is presented as a possible specialist-discovery option in Medical Oncology. This profile does not rank doctors, guarantee availability or predict the outcome of treatment.
About Dr. Mridul Malhotra
Current role and professional background
Information is paraphrased from the linked hospital profile and clearly separated from InMedism’s facilitation role.
Dr. Mridul Malhotra serves as Consultant - Medical Oncology at Manipal Hospital, Dwarka, New Delhi. The published practice location is Dwarka, New Delhi, India. The doctor-specific hospital record describes a clinical focus in Cancer Care. Clinical interests published in that record include Cancer Care, Precision Oncology: Tailoring treatment plans for cancer patients based on genomic testing and molecular profiling., Solid Tumor Management: Specializing in the diagnosis and treatment of solid tumors, including but not limited to:, Head and Neck Cancers, Gastrointestinal Cancers (Hepatobiliary Cancers, Pancreatic Cancer, Gastric Cancer, Colorectal Cancers). Published qualifications include MD (Medicine) | DM (Medical Oncology, TMH-Mumbai). Current hospital association, appointment availability and suitability for an individual case must be reconfirmed before travel.
International patients may use this information to identify a possible consultation route. The treating hospital must reconfirm the current appointment, availability, credentials and whether the case falls within the specialist’s practice.
Published professional experience
- Current published role: Consultant - Medical Oncology
- Associated hospital: Manipal Hospital, Dwarka, New Delhi
Earlier positions were not separately stated in the reviewed source record and should be confirmed before publication as fact.
Clinical interests described publicly
- Cancer Care
- Precision Oncology: Tailoring treatment plans for cancer patients based on genomic testing and molecular profiling.
- Solid Tumor Management: Specializing in the diagnosis and treatment of solid tumors, including but not limited to:
- Head and Neck Cancers
- Gastrointestinal Cancers (Hepatobiliary Cancers, Pancreatic Cancer, Gastric Cancer, Colorectal Cancers)
- Urological Malignancies (Renal Cell Carcinoma, Urothelial Malignancies, Testicular Tumors)
- Gynaecological Malignancies(Cervix, Uterine Cancer, Ovaries, Vulva, etc)
- Patient Advocacy: Empowering patients to make informed decisions about their care and advocating for their needs within the healthcare system, including access to treatments for all types of solid tumours.
- Global Health Initiatives: Participating in international conferences, research collaborations, and medical missions to address cancer disparities and improve access to treatments for solid tumours worldwide.
- Continuous Learning: Staying abreast of the latest advancements in oncology and immunotherapy through ongoing education, research, and professional development, with a focus on addressing the diverse needs of patients with solid tumours.
- Extraadrenal Pheochromocytoma-case report of refractory hypertension. Singh VP, Singh M, Malhotra M, Kumar A, Agarwal AK. Indian heart J. Mar Apr; 64(2):203-5
- Prevalence of diabetic retinopathy in type 2 diabetes and its correlation with various clinical and metabolic factors. Malhotra M, Lal AK, Singh VP, Malik PK, Arya V, Agarwal AK, Ind J Dia Dev Ctries 2014. DOI 10.1007/s13410-013- 0183-6.
- Cross-Sectional Study of Temozolomide-Induced Chemotherapy-Induced Nausea and
- M Malhotra, V Noronha, A Joshi, V Patil, S Wadhwa, K Prabhash. Real-world experience of ALK positive NSCLC from India, Annals of Oncology, Volume 30, Issue Supplement_2, April 2019, mdz063.075, https://doi.org/10.1093/annonc/mdz063.075
Professional memberships
- European Society of Medical Oncology
- American Society of Medical Oncology
- Indian Society of Medical and Pediatric Oncology
Areas of expertise
Conditions, procedures and care focus
These terms support discovery and are not a recommendation that any procedure is appropriate for an individual patient.
Cancer CarePrecision Oncology: Tailoring treatment plans for cancer patients based on genomic testing and molecular profiling.Solid Tumor Management: Specializing in the diagnosis and treatment of solid tumors, including but not limited to:Head and Neck CancersGastrointestinal Cancers (Hepatobiliary Cancers, Pancreatic Cancer, Gastric Cancer, Colorectal Cancers)Urological Malignancies (Renal Cell Carcinoma, Urothelial Malignancies, Testicular Tumors)Gynaecological Malignancies(Cervix, Uterine Cancer, Ovaries, Vulva, etc)Patient Advocacy: Empowering patients to make informed decisions about their care and advocating for their needs within the healthcare system, including access to treatments for all types of solid tumours.Global Health Initiatives: Participating in international conferences, research collaborations, and medical missions to address cancer disparities and improve access to treatments for solid tumours worldwide.Continuous Learning: Staying abreast of the latest advancements in oncology and immunotherapy through ongoing education, research, and professional development, with a focus on addressing the diverse needs of patients with solid tumours.Extraadrenal Pheochromocytoma-case report of refractory hypertension. Singh VP, Singh M, Malhotra M, Kumar A, Agarwal AK. Indian heart J. Mar Apr; 64(2):203-5Prevalence of diabetic retinopathy in type 2 diabetes and its correlation with various clinical and metabolic factors. Malhotra M, Lal AK, Singh VP, Malik PK, Arya V, Agarwal AK, Ind J Dia Dev Ctries 2014. DOI 10.1007/s13410-013- 0183-6.Cross-Sectional Study of Temozolomide-Induced Chemotherapy-Induced Nausea andM Malhotra, V Noronha, A Joshi, V Patil, S Wadhwa, K Prabhash. Real-world experience of ALK positive NSCLC from India, Annals of Oncology, Volume 30, Issue Supplement_2, April 2019, mdz063.075, https://doi.org/10.1093/annonc/mdz063.075
Career and academic context
Relevant professional highlights
These points help patients understand the published scope of experience; they do not predict an individual treatment outcome.
- Dr. Mridul garnered prestigious travel grants for his poster presentation at the European Lung Cancer Congress (ELCC) 2019, focusing on the real-world experience of ALK-positive NSCLC patients in India. The presentation shed light on novel insights into ALK-positive NSCLC management, emphasizing Dr. Mridul's commitment to advancing oncology research and patient care. https://doi.org/10.1093/annonc/mdz063.075
- Dr. Mridul was honored with travel grants for ESMO Asia 2017(Singapore) for his/her paper presentation at the Indian Cancer Congress 2017 in Bengaluru. The presentation delved into outcomes with second-line chemotherapy in advanced pancreatic cancers, drawing from a retrospective study conducted at a Tata Memorial Hospital, Mumbai in India.
Important interpretation
Procedure volumes, awards and “first” claims are hospital-reported where stated. InMedism has not independently audited those claims. Treatment suitability and risk must be discussed with the treating team.
International consultation
How InMedism can coordinate the next step
After receiving a concise case summary, InMedism can identify the hospital channel, organize the record set and request a consultation or preliminary review. The hospital may ask for additional tests, imaging files or pathology before responding.
- Prepare recent reports and the clinical question
- Confirm the appropriate hospital department
- Request availability and case review
- Coordinate travel only after hospital guidance
Independent patient coordination
Requesting an enquiry about Dr. Mridul Malhotra
InMedism provides independent medical-travel coordination and does not represent the doctor or hospital.
Independent listing disclosure
Dr. Mridul Malhotra is independently listed on InMedism® using the identified public hospital source. Inclusion does not imply partnership, affiliation, agency, endorsement, authorization, representation or an exclusive relationship with the doctor or Manipal Hospital, Dwarka, New Delhi.
International patients may ask InMedism to organize their reports and coordinate an enquiry through the hospital’s available communication channels. The doctor and hospital independently control availability, case acceptance, consultation, treatment decisions, estimates and outcomes.
The coordination process may include record preparation, hospital-channel communication, medical-visa guidance, travel, accommodation, interpretation and follow-up support. Patients should confirm every clinical and financial detail directly with the treating hospital.
Conclusion
Considering this specialist for your case
Dr. Mridul Malhotra is presented here on the basis of the official hospital profile, including the published role in Medical Oncology and association with Manipal Hospital, Dwarka, New Delhi. This information can support initial specialist discovery, but it does not establish suitability for an individual patient or guarantee a result.
Patients should request a formal review of current reports and confirm the doctor’s availability, proposed treatment pathway, risks, expected recovery, estimated hospital charges and follow-up requirements before making travel decisions.
Request coordinated case reviewSources and verification
Official hospital doctor profile ↗Primary profile source
Last checked 25 August 2026. Doctor titles, credentials, location and availability can change.
Contextual guidance
Questions about consulting Dr. Mridul Malhotra
These answers provide general coordination information. Questions about diagnosis, risks or treatment require a qualified clinician.
Ask a different question →Can InMedism confirm an appointment with Dr. Mridul Malhotra?+
InMedism can submit a consultation request through the appropriate hospital channel. The doctor and hospital independently control availability, case acceptance and scheduling.
Does this profile confirm that Dr. Mridul Malhotra is suitable for my case?+
No. A qualified clinician must review the diagnosis, reports, treatment history and current condition before suitability can be determined.
Where did InMedism verify this doctor information?+
The profile was checked against the official hospital doctor page linked in the Sources and verification section. Titles, availability and hospital associations can change.
What records should an international patient prepare?+
Useful records commonly include a concise medical summary, recent reports, imaging and pathology where relevant, prior treatment records, current medicines and the specific question for the specialist.